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Abstract
The preconceptional presence of microbiota in the female and male reproductive organs suggests that fertilization is taking place in a nonsterile
environment and contributes to reproductive success. The concept of embryonic development in a sterile uterus has also been challenged with recent
reports of the existence of a microbiome of the placenta, amniotic fluid and the fetal gut in normal, uncomplicated pregnancies. The maternal origins of
the microbiota colonising the fetus and its surroundings are unknown as are the mechanisms of maternal-to-fetal transfer. In this review, we aim to
highlight the preconception male and female microbiome, the maternal vaginal and gut microbiome during pregnancy and the fetal microbiome,
including their possible roles in reproduction, and maternal and neonatal pregnancy outcome.
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Introduction
The presence of microbes during pregnancy has for decades been
associated with inflammation, disease and adverse pregnancy out-
comes, such as preterm birth.1 However, this was under the long
prevailing assumption that the human body, including the uterus
and placenta were sterile sites. Recent evidence, however, demon-
strates a unique set of microbiota in the vagina,2 uterine cavity3
and placenta4 in healthy pregnant women, which challenges this old
adage that the embryo and fetus develop in a sterile environment.
The microbiota of the human body include bacteria, viruses,
fungi, yeast and archaea. The term microbiome refers to the total
genomic content of these microorganisms, but has nowadays
become interchangeable with the term microbiota. Most of the micro-
biome research has focussed on the human gastro-intestinal tract
hosting most of the microbiota across the body sites.5 It is known
that the local gut microbiome is involved in the digestion of foods,
synthesis of vitamins, host metabolism, defense against pathogens,
and immune responses, such as suppressing inflammatory responses
and promoting immunological tolerance via the innate immune
system.6,7 The host-microbiome relationship can be beneficial, sym-
biotic and well-balanced, whereas a disruption in the local balance or
composition of the microbiome can result in an unhealthy state of
dysbiosis, which is among others associated with inflammation and
disease (reviewed in Knight et al.8).
The Human Microbiome Project2,9 revealed the presence of a
microbiome in different human anatomical niches, such as gut, oral
cavity, skin and vagina. Besides a diversity in the residing commensal
microbes (alpha-diversity) at each site within each individual, there is
also a difference between individuals in diversity in the microbial
composition at each site (beta-diversity).2 These differences are influ-
enced by diet (Table 1), host genetics, body mass, early microbial
exposure and antibiotics (reviewed in Turnbaugh et al.8). For a few
years, it has been known that also the endometrium,3 placenta,4
amniotic fluid,10 seminal fluid11 and fetal gut12 have their own diverse
and unique set of microbiota.
The amount of biomass (the number of microbiota of a tissue or a
sample) is a continuous matter of controversy and debate. It is almost
impossible to prevent contamination of a sample with DNA present
in the air13 or laboratory reagents.14,15 Because of the high number of
microbiota of various microbiome niches, the impact of contamina-
tion will be limited. However, in samples with a low biomass, such as
seminal fluid,11 placenta,4 amniotic fluid10,16 and meconium,17 the
possibility exists that the contaminating DNA will dominate the
result of the microbiome analysis.15 The challenge in interpreting
microbiome research data is to approach contradicting results with
this in mind.
In the present review, we aim to give an overview of the literature
about the preconceptional and pregnancy microbiome at different
sites and its impact on reproduction, fetal development and pregnan-
cy outcome, with a focus on bacteria.
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Preconception
The preconception period is important for pregnancy outcome, since
preconception conditions (Table 1), such as diet and lifestyles have
significant impact on reproductive success (reviewed in Steegers-
Theunissen et al.18) and influence the composition of the gut micro-
biome during pregnancy.19 Also, at the core of successful conception
and subsequent pregnancy lies the preconception maturation of
female and male gametes. Therefore, it could be assumed that the
microbiome during the preconception period contributes to pregnan-
cy outcome. Herewith in line are the recent reports showing that the
microbiome of the follicular fluid20,21 and endometrium are associat-
ed with implantation success.22 In the next paragraphs, we describe
the preconceptional microbiome of follicular fluid, semen, uterus
and vagina.
Microbiome of follicular fluid
Oocyte maturation occurs within the environment of the follicular
fluid of the developing follicle. Pelzer et al.20,21 showed that the
human follicular fluid in women undergoing IVF cycles is not sterile,
but colonized with microbiota. To discriminate between procedure-
related contamination and in vivo colonisation, the follicular fluids
were classified as either contaminated when the detected microbiota
in follicular fluid were also detectable in the vagina during transva-
ginal oocyte retrieval and colonized when the microbiota were only
present within the follicular fluid. The most prevalent microbiota
detected in colonized follicular fluids were Lactobacillus spp.
(L. crispatus, L. gasseri, Actinomyces spp. and Propionibacterium
spp.). It has been suggested that the follicular fluid microbiome influ-
ences the outcome of IVF treatment, since the presence of
Lactobacillus spp. is associated with better embryo quality leading
to significantly higher rates of embryo transfer and pregnancy.21
The antimicrobial properties of lactic acid, the major acid metabolite
produced by Lactobacillus spp., can protect against adverse micro-
biota during oocyte maturation.23 Interestingly, the follicular fluid of
the left compared to the right ovary contains significantly more
microbiota, perhaps due to the asymmetrical vascularisation of the
gonads,21 pointing towards distribution of microbiota via the
blood stream.
Microbiome of semen
Up until now, the microbiome of the interieur milieus during sper-
matogenesis, such as that of the testis or epididymis, have not been
reported. However, the microbiome of the ejaculate has been ana-
lysed and most likely represents the presence of microbiota from all
contributing sites of the male reproductive tract, including
epididymis, seminal vesicles, prostate, bulbourethral glands and ure-
thra. It revealed that semen contains the strictly anaerobic Prevotella
and high proportions of facultative anaerobic bacteria of which the
most abundant bacteria are Lactobacillus, Pseudomonas, Gardnerella,
Finegoldia, Corynebacterium and Staphylococcus.11,24 Based on the
microbiome composition of the semen samples analysed so far, dif-
ferent seminal types can be identified, dominated by either
Lactobacillus, Pseudomonas or Prevotella.11,24 However, it is still
unknown whether the microbiome of semen is associated with male
fertility or semen quality, although Weng et al.24 found a positive
association of a Lactobacillus dominated microbiome with semen
quality. The latter could be explained by the high levels of lactic
acid synthetized by Lactobaccilus, which could protect against
the negative influence of Gram-negative bacteria during
spermatogenesis.23,24
The seminal microbiome has a lower biomass, but a higher diver-
sity of the microbiome compared to the vaginal microbiome (see
below) and induces a significant change in the vaginal microbiome
after intercourse.25 As the seminal fluid and its microbiome get into
contact with the endometrial fluid, a similar change in the endome-
trial microbiome could also occur. Hypothetically, an endometrial
microbiome change and mixing of the endometrial and seminal
fluid can influence the maternal–embryonic interaction during
implantation and placentation. Supportive of this hypothesis, are
experiments in rodent models that show an essential role for seminal
fluid in enabling successful embryo implantation and optimal placen-
tal development (reviewed in Robertson and Sharkey26).
The uterine/endometrial microbiome
Verstraelen et al.3 showed in a group of women (n¼ 19) with a variety
of reproductive conditions by endometrial biopsies that the uterine
microbiome mainly seems to consist of three bacterial phyla, in par-
ticular Proteobacteria, Firmicutes and Bacteroidetes, with
Bacteroidetes being the most dominant phylum in the majority of
the women included.3 Importantly, species diversity and richness of
the endometrium were significantly higher than that in the adjacent
vaginal compartiment (see below). The endometrium is suggested to
be colonized with both vaginal and gut microbiota, since microbiota
associated with the gastrointestinal tract, such as Bacteroidetes
(Bacteroidetes xylanisolvens, Bacteroidetes thetaiotaomicron,
Bacteroidetes fragilis) and Proteobacteria, as well as microbiota asso-
ciated with the vaginal microbiome, such as Lactobacillus iners,
L. crispatus and Prevotella amnii, were all identified in the endome-
trial samples.3
A different microbiome was found in endometrial fluid aspirates,
with the most abundant genera being Lactobacillus, Gardnerella,
Bifidobacterium, Streptococcus and Prevotella.22 Importantly, a
Table 1. Exposures or conditions that affect the human maternal microbiome during the preconception period and pregnancy.
Exposure/condition Timing Affected microbiome
Maternal diet19,94 Preconception Gut
Antibiotics95 Preconception Gut
BMI42,86,96,97 Preconception Gut, meconium (vaginal delivery)
Overweight / obesity96,98,99 Preconception Gut
Diabetes mellitus100 Preconception Meconium
Pregnancy34,35,37,40,41 Pregnancy Gut, vagina
Maternal diet19,101 Pregnancy Gut, placenta, meconium
Probiotics101,102 Pregnancy Placenta, meconium, Vagina
Overweight/obesity42,45,46 Pregnancy Gut
Gestational diabetes100,103 Gut, placenta, meconium
Gestational weight gain19,42,45,96 Pregnancy Gut, placenta
Chorioamnionitis4,66,104 Pregnancy Placenta, amniotic fluid
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Lactobacillus-dominated microbiome of the aspirates was associated
with higher chance of live birth, whereas the presence of other bac-
teria, especially for Gardnerella or Streptococcus genera, seemed to be
correlated with implantation failure or early pregnancy loss.22
Microbiome of vagina
The non-gravid vaginal microbiome is complex and in most women
dominated by four Lactobacillus spp., i.e. L. crispatus, L. iners,
L. jensenii or L. gasseri.27–29 Some women show a vaginal micro-
biome less dominated by Lactobacillus spp. and have more strict
anaerobes.27–29 Ethnicity is of influence on the vaginal microbiome,
since several studies showed that healthy, non-pregnant women from
European descent have a Lactobacillus-dominated vaginal micro-
biome, whereas healthy non-pregnant African-American and
Hispanic women have a non-Lactobacillus-dominated micro-
biome.28–30 In addition, the vaginal microbiome is dynamic and
seems to be affected by the menstrual cycle, the dominant microbiota
and sexual activity.27
The diversity of the non-pregnant vaginal microflora may be
important for pregnancy outcome, since at the time of embryo trans-
fer, the vaginal microflora seems to be an important factor in the
success of the IVF-embryo transfer procedure: A vaginal microbiome
composed solely of Lactobacillus (L. crispatus, L. iners, L. jensenii,
L. gasseri or other Lactobacillus species) at the moment of menses
before embryo transfer is associated with a successful outcome of the
IVF-ET procedure.31
In summary, recent research has repeatedly demonstrated the
existence of a microbiome in the male and female reproductive
organs and changed the perception of sterile fertilization. The
increasing evidence that the presence of microbiota in the female
reproductive tract plays a role during the process of implantation,
indicates that residing microbiota of the male and female reproduc-
tive tract around the conception could influence, both beneficially or
detrimentally, local immune responses and direct the process of
embryo implantation and subsequent placental development
and function.
Pregnancy
Around fertilization and during pregnancy, the maternal body under-
goes a series of physiological adaptions to prepare for support, pro-
tect and nurture the embryo and fetus.32,33 Besides anatomical,
biochemical and immunological adaptions, the residing microbiome
in the maternal body undergoes changes in parallel (Table 1). We are
only beginning to understand which roles the maternal and paternal
microbiota are playing during pregnancy. In line with the current
knowledge about the interactive roles of the gut microbiome, not
only dysbiosis in the gut, but also dysbiosis in the endometrium,
vagina and placenta during pregnancy, could potentially lead to
inflammation or disease. These changes may increase risk of adverse
pregnancy outcomes, such as miscarriage and preterm birth. In the
next paragraphs, we describe the pregnancy microbiome at different
locations (Figure 1).
Maternal microbiome
Microbiome of the vagina
After implantation, the dynamics and stability of the vaginal micro-
bial community change during the course of pregnancy (Tables 1
and 2). During the first trimester, a dominance of genus
Lactobacillus in the vaginal microbiome of Caucasian women is
observed.34–37
As pregnancy progresses beyond the first trimester, lesser diversity
and richness combined with an increased stability are seen.34–39 Also,
various species of Lactobacillus, such as L. iners, L. crispatus,
L. jensenii and L. johnsonii, are enriched in pregnancy.34
Figure 1. Overview of the maternal and fetal microbiome during pregnancy, health effects and maternal–fetal microbiome axes.
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With continuation of pregnancy, in some women, a shift from one
Lactobacillus-dominated to another Lactobacillus-dominated com-
position occurs,40 whereas in other women, a specific increase in
Lactobacillus is accompanied by a decrease in anaerobic micro-
biota.37 While the vaginal microbiome varies during the course of
pregnancy, around term, the vaginal microbiome seems to return to
a non-pregnant composition.34
Women with a relatively stable vaginal microbiome throughout
pregnancy, in terms of richness and diversity, seem to deliver more
often at term, whereas women with a decrease of richness and diver-
sity of the vaginal microbiome early in pregnancy seem to be at risk
of preterm birth.35,36,39 So far there are no indications that the com-
position of the vaginal microbiome before pregnancy predicts the
dynamics during pregnancy and pregnancy outcome.39
Microbiome of the gastrointestinal tract
During the first trimester of pregnancy, the maternal gut microbiome
is comparable to the microbiome in the preconceptional period.41
However, with progression of the pregnancy, the total number of
microbiota increases (Table 1), paralleled by an overall increase in
Proteobacteria and Actinobacteria.41,42 It has also been shown that
levels of Faecalibacterium are decreased during the third trimester of
pregnancy.41 Whereas within the gut of individual women the general
diversity and richness decrease (alpha diversity), between women the
diversity increases (beta diversity).41 Another study, however, showed
no changes in the gut microbiota during pregnancy or upon deliv-
ery,35 indicating that more research is needed into the maternal
microbiome during pregnancy.
Animal research showed that germ-free mice transplanted with
third trimester stool microbiota of pregnant women as compared to
germ-free animals treated with first trimester stool microbiota of
pregnant women had reduced glucose tolerance and more weight
gain.41 These effects suggest that the maternal gut microbiome has
an active role in the metabolic changes observed during pregnancy. In
view of the effect of the gut microbiota on immune responses,6,7
changes in the maternal gut microbiota during pregnancy could
also have an impact on the maternal immune system. Adaptations
of the maternal immune response during pregnancy are necessary to
accept and prevent rejection of the semi-allogenic fetal tissues, while
simultaneously maintaining its defence mechanism against microbes
to ensure maternal and fetal survival during the same period
(reviewed in Mor et al.43).
Also during pregnancy,44 the maternal gut microbiome is strongly
influenced by dietary patterns.19 A recent study showed that the
maternal diet in mice during the periconception period and during
pregnancy led to significant changes in the gut microbiome and met-
abolic pathways throughout pregnancy. In addition, obesity during
pregnancy is associated with a different maternal gut microbiome
composition (Table 1),42,45,46 characterized by increased Bacteriodes
and Staphylococcus.42
Changes in the gut microbial composition between the first and
third trimester are suggested to be involved in supporting the chang-
ing metabolic and immunological needs of the maternal body.
However, there are indications that microbiota are also important
for fetal growth and development, since as described below, transfer
of microbiota from the mother to the fetus takes place.
Embryonic and fetal microbiome
After reaching the uterine cavity, the blastocyst hatches so that the
trophectoderm, the outer extra-embryonic layer, is able to invade the
maternal endometrium and reach the local microbiome. The three
embryonic cell lines, the epiblast, trophectoderm and hypoblast,
will give rise to the different embryonic and extra-embryonic tissues.
Epiblast and trophectoderm chorion most likely contribute to the
chorion,47 whereas the epiblast will give rise to the embryo proper
and the amnion.47 Around 17–20 weeks of gestation, the inner amni-
otic membrane will fuse with the outer chorion to form the double-
layered chorioamniotic membrane.48 In order to form the placenta,
cells of the trophectoderm will invade the maternal spiral arties to
remodel them. Initially, these cells accumulate in the lumen to form
trophoblast plugs49 blocking maternal blood flow to the placenta
until the end of the first trimester, when they disintegrate.50
Many pregnancy complications, such as preeclampsia, fetal
growth restriction and abruption placentae, but also preterm birth,
premature rupture of membranes and late spontaneous abortion are
associated with disorders of deep placentation.51 Suboptimal invasion
of the endometrium and aberrant spiral artery remodelling will result
in placental insufficiency,52,53 which will often lead to (iatrogenic)
preterm birth because of fetal distress caused by either inadequate
placental attachment and uteroplacental ischemia or premature pla-
cental detachment. As such, these pregnancy complications often find
their origin during embryonic implantation.52
Implantation is accompanied by an interactive immunological
dialogue between local cytokines, chemokines, the maternal
immune system and the developing embryo. More recently, Mor
et al.43 have hypothesized a role for the local microbiome in this
interactive immunological dialogue. Although unknown so far, it is
feasible that also the seminal and endometrial microbiome may play a
role in the process of implantation and placentation.
Table 2. Dynamics of local microbiomes preconceptionally and during pregnancy.
Location Timing Dynamics
Maternal-preconception
Ovary20,21 Preconception Unknown
Uterine/endometrium22 Preconception Stable
Vagina27,34,40 Preconception Highly dynamic
Gut2,41,42 Preconception Stable – diet dependent
Maternal-pregnancy
Vagina34,39,40 Pregnancy Increased stability with each trimester
Gut41,42 Pregnancy Dynamic – trimester dependent, increase microbial load
Oral105 Pregnancy Dynamic – trimester dependent, increase microbial load
Fetal
Placenta4 Pregnancy Unknown
Amniotic fluid10 Pregnancy Unknown
Fetal membrane10 Pregnancy Unknown
Umbilical cord64 Pregnancy Unknown
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In the following paragraph, we will give a summary of the micro-
biome of the fetus and its environment (Figure 1).
Microbiome of the placenta
Stout et al.54 used high magnification imaging in combination with
the use of histologic tissue staining and observed intracellular micro-
organisms in the basal plates of 27% of both preterm and term
placentas. More importantly, the apparent evidence of the presence
of microbiota was found without any histological or pathological
signs of infection. Parnell et al.55 found significant differences
between the microbiome of the basal plate and the placental villi.
Proteobacteria, Actinobacteria, Bacteroidetes, Cyanobacteria,
Firmicutes, and Spirochaetes were detected in the basal plate, whereas
the placental villi harboured Acidobacteria, Actinobacteria,
Firmicutes, Proteobacteria, and Spirochaetes. This may be related to
different susceptibility of the different spatial compartments of the
placenta to infection and specific pathogens.56–59
The combination of 16S rDNA and whole-genome shotgun meta-
genomic techniques showed that the placenta exhibits its own unique
microbiome, with a low abundance but a metabolically rich micro-
biome. The placental microbiome largely consists of nonpathogenic
commensal microbiota from the phyla of Firmicutes, Tenericutes,
Proteobacteria, Bacteroidetes, and Fusobacteria4 and mostly resem-
bles that of the oral cavity4 and the deep endometrium of non-
pregnant women3 rather that of the adjacent vaginal microbiome.2
This is in contrast to another study which failed to identify a distinct
placental microbiome and ascribed the detected bacteria of the pla-
centa samples to bacterial contamination of the environment or the
reagents used.60
Although, the presence of commensal, symbiotic placental micro-
biota seems increasingly valid, the presence of pathological microbes
or a potential local dysbiosis can lead to adverse pregnancy out-
comes. A different microbiome, as compared with normal pregnancy
outcome, has been detected in placentas of pregnancies complicated
by preterm birth.61 The microbiota found in the preterm placenta
were similar to those commonly residing in the vagina (Prevotella
bivia, Lactobacillus spp., Peptostreptococcus magnus, or Gardnerella
vaginalis). In placentas of other pregnancy complications such as
preeclampsia or fetal growth restriction (FGR), the microbiota
Bacillus cereus, Listeria monocytogenes, Salmonella, Escherichia,
Klebsiella pneumoniae, Actinobacillus actinomycetemcomitans,
Fusobacterium nucleatum ssp., Porphyromonas gingivalis and
Prevotella intermedia have been cultured or sequenced.61–63
Since fetal viability, growth and development are completely
dependent on optimal placental function, the recent finding of a pla-
cental microbiome in healthy pregnancy may implicate a role for the
bacteria in normal fetal growth and development.
Microbiome of fetal membranes, umbilical cord
and amniotic fluid
Already in 2005, the presence of several different microbial DNA was
reported in the amniotic membranes of term healthy pregnancies of
women in or outside labour.63 More recently, the composition of
the microbiota in the fetal membranes was shown to consist
of Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria,
Spirochaetes. Although, most of these microbiota were also detect-
able in the basal plate and placental villi of the placenta attached, the
ratio of the different microbiota and total composition of the micro-
biome was significantly different between basal plate and placen-
tal villi.55
In 2005, Jimenez et al.64 reported the identification of bacteria in
umbilical cord blood from term neonates born via elective caesarean
section. The microbiota identified were Enterococcus faecium,
Propionibacterium acnes, Staphylococcus epidermidis, and
Streptococcus sanguinis, which are regarded as commensals in healthy
neonates.64
In healthy pregnant women, bacteria were found not only in the
placenta and umbilical cord blood, but also in the amniotic fluid.
A recent, elegant study comparing the microbiome of different mater-
nal and fetal samples collected during elective term caesarean section
showed that the microbiota in amniotic fluid were similar to the pla-
cental microbiota.10 The most prevalent phylum, Proteobacteria,
showed low abundance, low richness and low diversity, but with
high consistency across different individuals. Other phyla detected
were Enterobacter, and Escherichia/Shigella, Propionibacterium,
Lactobacillus, Streptococcus and Staphylococcus. Importantly,
besides microbial DNA, also viable microbiota were detected.10 In
addition, in amniotic fluid aspirated from healthy women between a
gestational age of 16 until 20 weeks and who delivered at term,
Ureaplasma spp. was detected.65
Although the reported bacterial findings seem not to be related to
adverse pregnancy outcome, different compositions of the micro-
biome of the amniotic fluid are associated with chorioamnionitis
(Table 1) and could even be used for prediction of preterm birth.66
The developing fetus is not only immersed in amniotic fluid, but
the swallowing and exchange of amniotic fluid are indispensable for
proper development of the fetal lung and gastrointestinal tract.16,67
Around term, the fetus will swallow around 1000 ml amniotic fluid
per day including the microbiota.68 The presence of amniotic bacteria
may thus aid in bacterial colonisation of the fetal gut. Indeed, con-
tinuous fetal amniotic fluid ingestion could then lead to colonization
of the fetal gut69 (see also below).
Microbiome of the fetal gut
In line with the observations that the amniotic fluid contains bacteria,
also the meconium as product of the fetal gut is not sterile.10,12,17 The
presence of Streptococcus, Enterobacteriaceae, such as Enterobacter
and Escherichia, Propionibacterium, Lactobacillus, Bacillales has been
reported; however, the dominant microbiota in meconium samples
seems to differ between studies.10,17 Although the meconium micro-
biome has a unique microbial composition, it shows significant
resemblance with both the microbiota of the amniotic fluid10,17 and
the placenta.10 These data suggest, in contrast to the general belief,
that colonization of the gut already occurs during pregnancy.
It thus seems increasingly evident that the fetal compartment,
including the placenta and membranes, are not sterile, but colonised
during pregnancy. The fetal gut may be colonised via the placenta
and amniotic fluid, since the meconium microbiome resembles the
microbiome of the placenta and amniotic fluid. The function of the
fetal microbiome is unknown; however, considering the effect of the
adult microbiome on immune responses and metabolism, it may be
speculated that the fetal microbiome is important for maturation of
the fetal immune response as well as for optimal setting of the fetal
metabolism (Figure 1).
The maternal–fetal microbiota axes
The mechanisms by which microbiota transfer from the mother to the
fetus are still unclear. However, it is not unthinkable that the routes
for seeding of maternal microbiota to the fetal environment are the
same as the suggested potential routes of intrauterine infection
(Figure 1).70 Although they could potentially contribute, iatrogenic
routes such as chorionic villus sampling, amniocentesis or blunt
external trauma, are not plausible as standard.
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The systemic blood circulation
The most obvious and effective route would be spreading via the
systemic blood circulation. During pregnancy, the cardiac output
directed toward the uterine arteries increases from 3.5% at the begin-
ning of pregnancy to 12% around term.71 The combined effect of all
maternal pregnancy adaptions leads to an increased uteroplacental
blood flow of 20–50 ml/min to 450–800 ml/min at term in singleton
pregnancies,72 which may contribute to delivering diverse microor-
ganisms to the fetal–maternal interface.
Direct evidence for a haematogenous maternal gut-fetal route
comes from animal studies showing that oral intake of genetically
labeled Enterococcus Fecium by pregnant mice could be traced back
in the amniotic fluid64 and meconium,73 whereas it could not be
detected in non-inoculated pregnant mice.64,73 Maternal dendritic
cells and leukocytes are suggested as trafficking cells for bacterial
uptake by placenta.74 Dendritic cells can cross the paracellular
space of the intestinal epithelium to directly ingest bacteria from
the intestinal lumen. However, dendritic cells are relatively ineffective
at killing internalized organisms, and bacteria can by way of dendritic
cells hematogeneously spread to other locations, such as the placen-
ta75 and be transferred to the fetus via the paracellular pathway of the
placental barrier76 into the amniotic fluid or the fetal blood circula-
tion via the umbilical cord.
The similarity of composition of the placental microbiome to the
microbiome of oral cavity4 and the longstanding association between
periodontal disease and adverse pregnancy outcome supports the
hematogenous shedding of periodontitis-associated bacteria
(reviewed in Cobb et al.77).
The peritoneal cavity
While all abdominal organs are enclosed in the subperitoneal cavity
by the peritoneum, the fallopian fimbriated ends are structures that
open into the peritoneal cavity.78 This makes retrograde spreading of
microbiota present in the peritoneal cavity fluid to the fetal compart-
ments another possible route of transfer of bacteria from the mother
to the fetus.
Increased intestinal permeability due to a change in microbiome
or inflammation41 could result in gut bacterial leakage into the peri-
toneal cavity.79 Inflammatory cells are known to spread across the
one cell-layer peritoneum into the peritoneal cavity.78 However,
whether the inflammatory state and shift in gut microbiome during
pregnancy leads to increased gut permeability and transfer of the gut
microbiome into the peritoneal cavity is unknown; however, the
ability of dendritic cells to cross the intestinal lumen74 suggests it
is possible.
The lower reproductive tract
Ascending maternal vaginal microbiota could also be a potential
source of microbiome of the fetal compartment,80 since DNA from
vaginal microbes has been found in amniotic fluid.81 The fetal mem-
branes are thought to form a barrier to ascending microorganisms,
which is supported by the fact that after prolonged (premature) rup-
ture of the membranes, intrauterine infection and preterm labour
often occur.82 Since the fusion of the fetal membranes to form a
barrier does not occur until 17–20 weeks of gestation,48 the uterine
cavity could still be accessible for ascending vaginal microbiota,
hereby potentially contributing to the early placental and
fetal microbiome.
Uterine cavity
The presence of a local residing uterine and endometrial micro-
biota3,22,83 indicates that during pregnancy, a local microbiome
may also be present. Since with implantation the fetal and maternal
compartment come into close contact, it is feasible that the uterine
and endometrial microbiome, and perhaps even the seminal micro-
biome, could contribute to the initial placental microbiome.
The main source of the microbiome of the fetal compartment
during pregnancy has to be maternal, however, despite different the-
oretical routes of spreading, it is unknown which, what and how the
maternal microbiome contributes to the microbiome of the fetal
compartments.
Birth
Despite microbial colonization of the fetal compartments, including
the fetal gut, the main maternal source of the postnatal microbiome
of the newborn immediately after birth is probably provided during
birth. Depending on the birth mode, vaginal delivery versus caesar-
ean section, the neonate has to respectively pass through the vagina
or the abdominal skin. The mechanistic process of being born exposes
the newborn to commensal bacteria colonizing the vagina, perineum
and skin, subsequently resulting in neonatal gut and skin
colonization.
Vaginal delivery leads to colonization of neonatal gut with
microbes resembling the maternal vaginal microbiota, such as
Lactobacillus, Prevotella and Bifidobacterium.84,85 On the other
hand, neonates delivered by caesarean section showed an intestinal
absence of vaginal microbes, e.g. Bifidobacterium,84 but the
presence of microbes resembling the microbial communities of
the maternal skin, such as Staphylococcus, Corynebacterium, and
Propionibacterium spp.85
Conclusion
The physiological state of pregnancy demands a significant adapta-
tion of the maternal body, including changes in the residing microbial
compositions and establishing a placental and fetal microbiome. In
addition, during the preconception period, the composition of the
male and female microbiome may also interfere with reproductive
success. However, it is still difficult to determine which microbial
composition is detrimental and optimal for the host or what the
exact function of the microbiome at each location is.
The changes in the maternal microbiome seem to support mater-
nal health, since it affects maternal metabolism,41 while also influenc-
ing maternal immune responses. On the other hand, changes in the
maternal microbiome could also be important for colonisation of the
fetus, most likely necessary for the development of fetal immune
responses and for inducing the metabolic settings (Figure 1).86,87 It
is therefore essential to understand the routes of microbial seeding
and how the fetal microbiome is established.
The potentially important role of the maternal and fetal micro-
biome in maternal, fetal and neonatal health prompts the question of
antibiotic use during pregnancy. Antibiotic treatment is associated
with disruption of the microbiome88,89 and with a large number of
health problems, such as metabolic and immunological diseases.88
Recent studies have shown that prenatal antibiotic use is associated
with an increased risk of childhood asthma90 and childhood obesi-
ty.91 There are speculations that this is due to the effect of prenatal
antibiotics on the maternal and fetal microbiome, resulting in dys-
biosis, with detrimental effects on health. In line with the DOHaD
theory,92 cautious use of antibiotics should therefore be indicated,
since the effect of in utero exposure on the establishment of the
fetal microbiome and postnatal development and health in later life
6 Obstetric Medicine 0(0)
is unknown, while it is known that the desired effect of preventing
adverse pregnancy outcome is minimal.70
In order to put the roles of the microbiome in maternal and fetal
physiology and pathology in perspective, the next steps in micro-
biome research should also include the interactive effects of other
microorganisms present, such as bacteria, viruses, fungi, yeast and
archaea. Racicot et al.93 showed that the cervix of pregnant mice is
more susceptible to viral infection as compared to the cervix of non-
pregnant mice. More importantly, a viral infection of the cervix
during pregnancy reduces the protection against ascending vaginal
bacteria. Besides, expanding the range of microbiota, combining
microbiome research with whole genome sequencing, metagenomics
and metabolomics are essential to interpret the potential effects of the
microbiome on maternal metabolism and epigenetics.
For the microbiome research focussing on the period of pregnan-
cy, we would like to propose to include the periconception period.
Not only do the results of the endometrial22 and vaginal micro-
biome39 suggest an interactive role around and during pregnancy,
effective lifestyle interventions during the preconception period
increase not only pregnancy chances, but also health in maternal
postpartum and neonatal life.18
This knowledge could lead to the development of pregnancy or
periconceptional novel dietary interventions, such as treatment with
pre- or probiotics, to prevent or correct certain dysbiotic states.
Preconceptional or early pregnancy microbiome data could be
future biomarkers to determine obstetrical and fetal health. The ulti-
mate goal would be, if necessary, to postpone a pregnancy to correct
a suboptimal and dysbiotic maternal (and paternal) microbiome com-
position to optimally prepare a couple for a future healthy pregnancy
and child.
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